Model
Edge
Takeda Pharmaceutical Co., Ltd.
TAK
Filing type
20-F
Filing date
Jun 27, 2023
Updated
Jun 28, 2023 ยท 12:07 AM
Copy reference
Filing
20-F
Annual and Transition Report of Foreign Private Issuers
Exhibits
EX-1.2
EX-1.2
EX-4.4
EX-4.4
EX-12.1
EX-12.1
EX-12.2
EX-12.2
EX-13.1
EX-13.1
EX-13.2
EX-13.2
EX-15.1
EX-15.1
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic